A new study by researchers could be a breakthrough in our fight against tuberculosis that has a long history. The researchers have identified an enzyme in the bacteria that causes TB, inhibiting which could kill the bacteria effectively. A first of its kind study, the researchers hope this enzyme can be targeted to develop effective drugs against TB without any side effects.
Researchers from JNCASR have developed an innovative method to activate thermally activated delayed fluorescence (TADF) molecules, by trapping it with light in a “optical cavity”.